Hindi Archives - Sidra Medicine

Qaisar Choudry

Dr. Qaisar Choudry joined Sidra Medicine as a Senior Attending Physician specializing in Pediatric Orthopedic Surgery and Trauma in December 2024. Born and trained in the UK, Dr. Choudry is an experienced orthopedic surgeon with over 20 years of clinical expertise. He previously served as a Pediatric Orthopedic Consultant and Chief of Orthopedic Surgery at East Lancashire Hospitals NHS Trust, England, for nine years.

Dr. Choudry completed pediatric orthopedic fellowships at Robert Jones Agnes Hunt Hospital, Oswestry, UK, and an orthopedic trauma fellowship at AO in Stuttgart, Germany. He has a particular interest in developmental dysplasia of the hip (DDH), cerebral palsy, sports-related knee injuries, and complex pediatric trauma.

Actively engaged in medical education and research, Dr. Choudry is an honorary lecturer and a member of the Faculty of Surgical Trainers of Edinburgh. He regularly contributes to medical literature and has received notable recognition, including the Jacques Duparc Award for best presentation at the EFORT Congress.

27 May, 2025

Sidra Medicine First Hospital in the Middle East to Successfully Perform Intraventricular Baclofen Therapy

Sidra Medicine, a member of Qatar Foundation, is the first hospital in the Middle East to successfully perform two Intraventricular Baclofen Therapies. The milestone highlights Sidra Medicine’s commitment to pioneering advanced neurosurgical treatments for children and young people with severe movement disorders.

20 May, 2025

Sidra Medicine Performs Qatar’s First-Ever Osia® Implant Hearing Procedure

Sidra Medicine, a member of Qatar Foundation, has taken a pioneering step in auditory healthcare by successfully performing Qatar’s first implantation of the OSIA® OSI300 hearing device. The implant is a next-generation osseo-integrated hearing device that overcomes many limitations of older bone conduction systems.

13 May, 2025

Sidra Medicine Signs Memorandum of Understanding with Great Ormond Street Hospital

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), one of the world’s leading pediatric hospitals. The agreement focuses on collaboration across key areas of clinical service, research, and education in children’s health.

11 May, 2025

Sidra Medicine Hosts First Royal College of Paediatrics and Child Health (MRCPCH) Clinical Exam in Qatar

Sidra Medicine, a member of Qatar Foundation, has successfully hosted Qatar’s first Membership of the Royal College of Paediatrics and Child Health (MRCPCH) Clinical Exam. Fifteen examiners participated in the examination process, assessing 48 candidates from across the region, who are pursuing certification with the Royal College of Physicians (RCP).

05 May, 2025

Sidra Medicine Study Pioneers Genome Assembly Approach for Rare Disease Research

Researchers at Sidra Medicine, a member of Qatar Foundation, have led a landmark study, published in Nature Genetics, unlocking the genetic causes of difficult-to-resolve rare diseases from diverse Middle Eastern populations.

03 May, 2025

Sidra Medicine to Host Inaugural MENA ART Conference

Advancing Precision Medicine with Flow Cytometry and Optical Microscopy 3 May 2024, Doha, Qatar - Sidra Medicine, a member of Qatar Foundation, will host its inaugural MENA ART (Advanced Research

30 April, 2025

Sidra Medicine and Children’s Hospital Los Angeles Sign Memorandum of Understanding

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Children’s Hospital Los Angeles (CHLA), marking the beginning of a new collaboration between the two leading pediatric healthcare institutions.

29 April, 2025

Sidra Medicine Zebrafish Study Investigates Gene Linked to Autism and Epilepsy

Sidra Medicine and Qatar Biomedical Research Institute (QBRI) at Hamad Bin Khalifa University, have published a groundbreaking study marking the first creation of an autism zebrafish model in Qatar, to investigate a rare genetic mutation associated with both autism and epilepsy. The study highlights the power of precision medicine in advancing our understanding of complex neurodevelopmental disorders.

20 April, 2025

Sidra Medicine Signs MoU with Vitafluence.ai to Advance AI-Driven Healthcare Innovation

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Germany-based Vitafluence.ai GmbH and its Swiss venture studio, EmpathicAI.Life, to explore potential collaborations in the field of artificial intelligence (AI) and digital health innovation.

If you have any questions or would like to schedule an appointment, please contact Sidra Medicine at 4003 3333.